Turn Scientific Complexity Into Confident Decisions — Instantly

Pienomial’s Knolens is an AI-powered pharmaceutical intelligence platform unifying scientific, regulatory, and clinical data into real-time, traceable insights. Founded in 2020, it supports Clinical, HEOR, and Market Access teams at biotech and pharma companies across Boston, New Jersey, and global hubs.z

View Our AI Solutions
Want a full experience?
Book a Demo

100+

Therapeutic Indications

Knolens covers 100+ indications in oncology, rare diseases, immunology, and cardiovascular therapeutics.

>80%

Faster Decisions

Knolens streamlines pharma insights, cutting data gathering from weeks to hours for faster decisions.

>95%

AI Accuracy

Knolens delivers real-time, regulatory-grade data with AI pipelines and knowledge graphs for drug development.

Built for decision-makers across drug development

HEOR and
Market Access

Knolens helps pharma companies model market access with real-time HTA data, track global reimbursement, and accelerate payer submissions. By strengthening evidence-based value narratives, Boston and New Jersey teams cut time-to-reimbursement 50–70% across US, European, and global markets with AI-powered intelligence.

Clinical
Development

Knolens helps clinical teams optimize trial design with AI scenario modeling of criteria, endpoints, and populations. By analyzing FDA/EMA study data, it delivers feasibility insights and protocol recommendations, enabling 40–60% faster trial startups and higher success rates through precedent-based optimization.

Knolens gives regulatory teams scenario-based insights on FDA labels, EMA pathways, and endpoint changes. It tracks global precedents, delivers AI-curated evidence, and enables faster responses. Regulatory affairs teams cut submission prep time 60% while boosting approval probability through optimized strategies.

Regulatory and
Medical Affairs

Competitive
Intelligence

Knolens enables CI teams to simulate market shifts, track pipelines, and run AI-driven scenarios. It anticipates competitor moves, detects early signals, and provides downstream impact analysis, giving pharma companies a 3–6 month competitive edge with predictive modeling.

New Product
Development

Knolens supports strategy teams by simulating integrated clinical, regulatory, and market strategies with real-world pharma data. It tracks endpoints, derisks go/no-go decisions, and aligns development with market access, reducing late-stage failures by 30–40% through AI-driven strategy modeling.

Strategy and
Forecast

Knolens empowers executives with real-time business scenario modeling by combining internal pharma data and market intelligence. It delivers defensible AI insights for strategic planning, helping C-suites optimize portfolio decisions, market entry timing, and resource allocation across therapeutic areas with predictive intelligence.

Knolens Product Suite

Frequently Asked Questions

We've covered most of the common questions below.

What pharmaceutical companies use Knolens?

Knolens serves biotech companies and pharmaceutical firms across major life sciences hubs including Boston's biotech corridor, New Jersey's pharmaceutical cluster, and European pharma centers. Client companies range from early-stage biotech startups to global pharmaceutical corporations.

How accurate is Knolens AI for regulatory submissions?

Knolens maintains >95% accuracy in data analysis and literature extraction, with full source traceability meeting FDA and EMA regulatory requirements for evidence-based submissions.

What therapeutic areas does Knolens cover?

Knolens covers 100+ medical indications across oncology, rare diseases, immunology, neurology, and other therapeutic areas commonly developed by pharmaceutical companies.

How does Knolens compare to traditional pharmaceutical intelligence tools?

Unlike legacy database platforms, Knolens provides real-time AI-powered analysis with natural language querying, reducing pharmaceutical intelligence gathering time by over 80% compared to manual methods.

Is Knolens suitable for both biotech startups and large pharmaceutical companies?

Yes, Knolens scales from Cambridge biotech startups to global pharmaceutical corporations, adapting to company size and specific pharmaceutical intelligence needs.

Didn’t find what you are looking for?  Book a Demo

Want to know more about
Knolens?

Book a free demo and learn more about Knolens, it’s offerings and use-cases. We would love to help you with all your queries.

Book a Demo